In-Licensing Opportunity Assessment in a Subsegment of Anticoagulant Agents for the EU-5 Market

Publications
Category:
Published on:
May 2, 2020
Written by:
Joris Pezzini

When our client, a renowned European pharma company, was interested in an in-licensing opportunity to drive its future growth while achieving significant commercial synergies, Alira Health performed a thorough analysis to understand the sales potential and value.

Read on to see how Alira Health’s in-depth analysis helped our client move forward with confidence.

For more information or for a PDF of this infographic, contact Joris Pezzini.

To know more about Alira Health Management Consulting services

Click here

Related news

Pharma
Events August 30, 2021
Event: German Biotechnology Days
Join Daniela Sica, VP Business Development, Pharma and Biotech at Alira Health and Barbara Pejic, Business Development Manager at CROS NT at German Biotech Days.
Pharma
Events August 19, 2021
Event: IPLS Autumn Workshop & Networking Reception
Join Daniela Sica at IPLS Autumn Workshop & Networking Reception.
Pharma Research & Development
Publications August 2, 2021
Infographic: Prioritization Strategy of R&D Targets for Biotech Company
Download our infographic on Prioritization Strategy of R&D Targets for Biotech Company
Due Diligence Pharma
News July 21, 2021
Alira Health Announces its Role as Strategic Advisor to Naxicap
Alira Health is proud to announce its role as strategic advisor to Naxicap in the equity investment in Ceres Pharma Bv.
Due Diligence MedTech Patient Engagement Pharma
Multimedia April 12, 2021
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)
M&A MedTech Pharma
News April 12, 2021
Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.